B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

Benzinga · 1d ago
B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $290 to $325.